Zeo ScientifiX, Inc. SEC filings ZEOX
Zeo ScientifiX, Inc. has 518 filings in SEC EDGAR's recent list, going back to Sep 4, 2012. Its latest annual report, Form 10-KT, was filed on Oct 13, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 15, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 30, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 26, 2026 | Oct 26, 2026 |
| 10-KT | Transition report | Oct 13, 2026 | Jun 30, 2026 |
| NT 10-K | Filing | Sep 28, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 15, 2026 | Sep 10, 2026 |
| 8-K |
Current report
Other events
|
Sep 15, 2026 | Sep 15, 2026 |
| NT 10-Q | Filing | Sep 14, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Other events
|
Aug 4, 2026 | Aug 4, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 24, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 24, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 24, 2026 | — |
| S-8 | Employee stock plan registration | Jul 24, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 21, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 8, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Other events
|
Jun 16, 2026 | Jun 16, 2026 |
| 10-Q | Quarterly report | Jun 15, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Other events
|
Jun 9, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Other events
|
May 27, 2026 | May 27, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 15, 2026 | — |
| 8-K |
Current report
Other events
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Other events
|
Apr 21, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Other events
|
Apr 9, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 7, 2026 |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 23, 2026 |
| 10-Q | Quarterly report | Mar 17, 2026 | Jan 31, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 6, 2026 | — |
| 3 | Initial insider ownership | Feb 6, 2026 | Jan 23, 2026 |
| 10-K | Annual report | Jan 29, 2026 | Oct 31, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 28, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 21, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 4 | Insider transaction | Jan 16, 2026 | Jan 14, 2026 |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2026 | Dec 24, 2025 |
| D | Filing | Dec 5, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Dec 3, 2025 | Nov 30, 2025 |
| 8-K |
Current report
Other events
|
Oct 23, 2025 | Oct 23, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Oct 20, 2025 | — |
| 10-Q | Quarterly report | Sep 15, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jul 29, 2025 | Jul 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2025 | Jul 18, 2025 |
| 8-K |
Current report
Other events
|
Jul 9, 2025 | Jul 9, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 25, 2025 |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 24, 2025 |
| 4 | Insider transaction | Jun 24, 2025 | Jun 18, 2025 |
| 10-Q | Quarterly report | Jun 16, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 11, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 6, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | May 23, 2025 | — |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| EFFECT | Filing | May 20, 2025 | — |
| S-1/A | Amended registration statement | May 16, 2025 | — |
| CORRESP | Letter to the SEC | May 16, 2025 | — |
| 4 | Insider transaction | May 16, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
May 12, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 12, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 8, 2025 |
| 4 | Insider transaction | May 7, 2025 | May 5, 2025 |
| 4 | Insider transaction | May 1, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | Apr 30, 2025 | Apr 28, 2025 |
| 4 | Insider transaction | Apr 25, 2025 | Apr 23, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 21, 2025 |
| S-8 | Employee stock plan registration | Apr 16, 2025 | — |
| 4 | Insider transaction | Apr 15, 2025 | Apr 11, 2025 |
| 4 | Insider transaction | Apr 7, 2025 | Apr 3, 2025 |
| 3 | Initial insider ownership | Apr 4, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2025 | Apr 1, 2025 |
| UPLOAD | Letter from the SEC | Mar 31, 2025 | — |
| DEL AM | Filing | Mar 27, 2025 | — |
| S-1 | Registration statement | Mar 26, 2025 | — |
| 10-Q | Quarterly report | Mar 17, 2025 | Jan 31, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 20, 2025 |
| 8-K |
Current report
Other events
|
Feb 18, 2025 | Feb 18, 2025 |
| 4 | Insider transaction | Feb 13, 2025 | Feb 11, 2025 |
| 8-K |
Current report
Other events
|
Feb 11, 2025 | Feb 11, 2025 |
| 3 | Initial insider ownership | Feb 10, 2025 | Feb 7, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Feb 10, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 10-K | Annual report | Jan 29, 2025 | Oct 31, 2024 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 7, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 7, 2025 | — |
| 4 | Insider transaction | Dec 30, 2024 | Dec 26, 2024 |
| 4 | Insider transaction | Dec 30, 2024 | Dec 30, 2024 |
| 4 | Insider transaction | Dec 20, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 19, 2024 | Dec 17, 2024 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 11, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 20, 2024 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Nov 22, 2024 | Nov 15, 2024 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 15, 2024 | Nov 15, 2024 |
| 8-K |
Current report
Other events
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Other events
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Other events
|
Sep 30, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Sep 20, 2024 | Sep 20, 2024 |
| 10-Q | Quarterly report | Sep 16, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Sep 3, 2024 | Aug 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Aug 12, 2024 | — |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Aug 7, 2024 | Jul 11, 2024 |
| D | Filing | Jul 16, 2024 | — |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 4 | Insider transaction | Jul 15, 2024 | Jul 11, 2024 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Jul 12, 2024 | Jul 8, 2024 |
| 10-Q | Quarterly report | Jun 14, 2024 | Apr 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 3, 2024 | May 31, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Apr 1, 2024 |
| 10-Q | Quarterly report | Mar 18, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Other events
|
Mar 4, 2024 | Mar 4, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 26, 2024 | Feb 20, 2024 |
| 10-K | Annual report | Jan 29, 2024 | Oct 31, 2023 |
| 4/A | Form 4/a | Dec 21, 2023 | Jun 28, 2023 |
| 4 | Insider transaction | Dec 20, 2023 | Dec 19, 2023 |
| DEF 14C | Information statement | Dec 20, 2023 | Dec 20, 2023 |
| 8-K |
Current report
Other events
|
Dec 12, 2023 | Dec 8, 2023 |
| PRE 14C | Filing | Dec 11, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Nov 27, 2023 | Nov 27, 2023 |
| 8-K |
Current report
Other events
|
Nov 14, 2023 | Nov 13, 2023 |
| PRER14C | Filing | Oct 19, 2023 | — |
| PRE 14C | Filing | Sep 28, 2023 | Sep 28, 2023 |
| 10-Q | Quarterly report | Sep 14, 2023 | Jul 31, 2023 |
| D | Filing | Aug 25, 2023 | — |
| DEF 14C | Information statement | Aug 14, 2023 | Aug 17, 2023 |
| 8-K |
Current report
Acquisition or sale of assets
|
Aug 9, 2023 | Aug 7, 2023 |
| PRE 14C | Filing | Aug 1, 2023 | Aug 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 26, 2023 | Jul 26, 2023 |
| 8-K |
Current report
Officer or director change
|
Jul 11, 2023 | Jul 11, 2023 |
| 4 | Insider transaction | Jul 11, 2023 | Jul 7, 2023 |
| 4 | Insider transaction | Jun 30, 2023 | Jun 28, 2023 |
| 4 | Insider transaction | Jun 30, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2023 | Jun 29, 2023 |
| 4 | Insider transaction | Jun 28, 2023 | Jun 26, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2023 | Jun 21, 2023 |
| 10-Q | Quarterly report | Jun 16, 2023 | Apr 30, 2023 |
| NT 10-Q | Filing | Jun 14, 2023 | Apr 30, 2023 |
| 3 | Initial insider ownership | Jun 9, 2023 | Jun 6, 2023 |
| 3 | Initial insider ownership | Jun 9, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Other events
|
Jun 9, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 6, 2023 | Jun 4, 2023 |
| 8-K |
Current report
Officer or director change
|
May 15, 2023 | May 12, 2023 |
| 8-K |
Current report
Officer or director change
|
May 1, 2023 | Apr 28, 2023 |
| 8-K |
Current report
Auditor change
|
Apr 21, 2023 | Apr 17, 2023 |
| 10-Q | Quarterly report | Mar 17, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Mar 8, 2023 | Mar 6, 2023 |
| UPLOAD | Letter from the SEC | Feb 22, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 14, 2023 | — |
| 10-K | Annual report | Feb 14, 2023 | Oct 31, 2022 |
| NT 10-K | Filing | Jan 30, 2023 | Oct 31, 2022 |
| UPLOAD | Letter from the SEC | Jan 20, 2023 | — |
| SC 13D | Ownership over 5% (active) | Dec 30, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2022 | Dec 21, 2022 |
| 3 | Initial insider ownership | Dec 16, 2022 | Aug 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 1, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Officer or director change
|
Nov 25, 2022 | Nov 22, 2022 |
| 8-K |
Current report
Other events
|
Nov 21, 2022 | Nov 21, 2022 |
| 4/A | Form 4/a | Nov 3, 2022 | Oct 31, 2022 |
| 4 | Insider transaction | Nov 1, 2022 | Oct 31, 2022 |
| 3 | Initial insider ownership | Oct 27, 2022 | Sep 23, 2022 |
| EFFECT | Filing | Oct 24, 2022 | — |
| S-1/A | Amended registration statement | Oct 20, 2022 | — |
| CORRESP | Letter to the SEC | Oct 20, 2022 | — |
| 4 | Insider transaction | Oct 17, 2022 | Oct 13, 2022 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
Oct 12, 2022 | Oct 12, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 12, 2022 | Oct 12, 2022 |
| 3 | Initial insider ownership | Oct 11, 2022 | Sep 23, 2022 |
| 3 | Initial insider ownership | Oct 6, 2022 | Sep 23, 2022 |
| 3 | Initial insider ownership | Oct 3, 2022 | Sep 23, 2022 |
| 3 | Initial insider ownership | Oct 3, 2022 | Sep 23, 2022 |
| 3 | Initial insider ownership | Sep 29, 2022 | Sep 23, 2022 |
| UPLOAD | Letter from the SEC | Sep 29, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Sep 27, 2022 | Sep 23, 2022 |
| S-1 | Registration statement | Sep 22, 2022 | — |
| 3 | Initial insider ownership | Sep 20, 2022 | Sep 13, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2022 | Sep 20, 2022 |
| SC 13D | Ownership over 5% (active) | Sep 16, 2022 | — |
| 3 | Initial insider ownership | Sep 16, 2022 | Aug 19, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ZEOX (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- NV
- Headquarters
- Davie, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1557376
- Former names
- Organicell Regenerative Medicine, Inc. (until Jan 29, 2024); Biotech Products Services & Research, Inc. (until Jun 15, 2018); BESPOKE TRICYCLES INC (until Sep 14, 2015)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.